Dental Tribune India
News
COVID-19 can lead to diabetes mellitus

June 13, 2021 | News

So far, the COVID-19 management has mainly focused on pneumonia and blood clots. Now evidence is building up on how COVID-19 recovered individuals can develop diabetes mellitus.

New study examines extent of occupational risk of COVID-19 in UK

June 12, 2021 | News

BIRMINGHAM, UK: To fill a research gap, researchers have recently examined whether dental professionals are, in fact, at an increased risk of becoming infected with SARS-CoV-2 in the workplace, as has often been hypothesised. They found that close contact with patients put dental professionals at a higher risk of developing COVID-19 during the first wave of the pandemic and that a large number of dental professionals had SARS-CoV-2 antibodies in their blood.

advertisement
COVID-19 and mental health

June 5, 2021 | News

Mind your mind because a dilapidated one is worse than having none. Dr. Bhavdeep Singh Ahuja emphasizes the importance of mental health in these challenging times.

Understand ventilation to curb COVID-19 risk

May 29, 2021 | News

Information on the transmission of the SARS-CoV-2 virus has constantly been evolving right from droplet spread to the virus being declared airborne. The acknowledgment of airborne transmission prioritizes ventilation along with masks, hand hygiene, and social distancing. This article focuses on ventilation, the most critical measure to curb the spread by intentionally introducing outdoor air into closed spaces.

Landmark resolution: Oral health back on global agenda

May 28, 2021 | News

The 74th World Health Assembly (WHA74) has approved the landmark resolution on putting oral health back on the global agenda.

advertisement
Mucormycosis dedicated center at ACPM, Dhule

May 27, 2021 | News

Jawahar Medical Foundation ACPM Medical College and the OMFS department of ACPM Dental College, Dhule, have set up a center dedicated to treat and manage post-COVID mucormycosis cases.

Acetic acid to prevent mucormycosis – Dr. Puneet Wadhwani (OMFS)

May 25, 2021 | News

The Covid-19 pandemic has unleashed a flood of Mucormycosis cases in India. All specialists - the ENT/ ophthalmic/ maxillofacial surgeons, physicians, and radiologists are working on its early diagnosis, early radical surgical debridement, and medical management with Liposomal Amphotericin B. However, it is equally critical to explore the other end of the spectrum, i.e., the site of initial fungal spore invasion-the nostrils. Dr. Puneet Wadhwani (OMFS) suggests the use of acetic acid as a simple, readily available, and inexpensive measure - worth exploring further for the prevention of mucormycosis.

Mucor due to hyperglycemia from new strain?

May 23, 2021 | News

As the medical fraternity gets busy identifying the risk factors and causative factors behind mucormycosis, a clinical observation of six months suggests it could be due to severe hyperglycemia caused by the new variant of SARS-CoV-2.

advertisement
Indian SARS-CoV-2 variant B.1.617.2: Part 3

May 21, 2021 | News

This is a series of updates by Dr. Rohan Bandi (MDS) Prosthodontist, Mumbai on the emerging lines of evidence on B.1.617.2, the Indian variant of SARS-CoV-2. Part 3 of the series describes the current status of B.1.617 and the impact of its mutations on the vaccines .

Now a T-cell-based clinical test for COVID-19

May 18, 2021 | News

Our interest in the significance of T-cell immunity in fighting SARS-CoV-2 infection and in providing resistance to re-infection is only growing more. Now, we have the first clinical T-cell-based test for patients to confirm recent or prior COVID-19 infection.

Indian SARS-CoV-2 variant B.1.617.2: Part 2

May 15, 2021 | News

This is a series of updates by Dr. Rohan Bandi (MDS) Prosthodontist, Mumbai on the emerging lines of evidence on B.1.617.2, the Indian variant of SARS-CoV-2. Part 2 of the series describes the basics of B.1.617 and clarifies the different terms used in the description of variants, especially the Indian variants.

Sumita Mitra nominated for European Inventor Award 2021

May 12, 2021 | News

Sumita Mitra, an Indian-American chemist, has been nominated as a finalist for the European Inventor Award 2021 for applying nanotechnology to produce a new composite restorative material, which has many advantages over conventional materials.

advertisement
Indian SARS-CoV-2 variant B.1.617.2—Part 1

May 11, 2021 | News

This is a series of updates by Dr. Rohan Bandi, a prosthodontist from Mumbai, on the emerging updates on B.1.617.2 the Indian variant of SARS-CoV-2.

Breakthrough COVID-19 infections among the vaccinated may not be a severe threat

May 10, 2021 | News

As the COVID-19 vaccination drive continues to expand throughout the world, SARS-CoV-2 variant mutations and breakthrough infections have posed a new public health concern.

Are new SARS-CoV-2 variants escaping PCR detection?

May 9, 2021 | News

Several media reports have come up with scary headlines that the new SARS-CoV-2 variants are fooling the RT-PCR test, which is considered the gold standard test for detecting the SARS-CoV-2 infection. Anecdotal reports say PCR tests are not able to detect the virus due to the new mutations. Is it true? Let us explore science and find out the truth.

WHO statement on airborne transmission of SARS-CoV-2

May 4, 2021 | News

The World Health Organization (WHO) updated its communication on the airborne transmission of SARS-CoV-2 on 30 April 2021. This article summarizes their current opinion.

Saliva test for COVID-19 diagnosis and severity prediction – Dr. Amisha Parekh

April 29, 2021 | News

The use of saliva has multiple advantages over nasopharyngeal swabs in terms of being non-invasive, its ease of collection without professional help, and without the need for transport media. The growing evidence on saliva being as accurate as nasopharyngeal swab test makes it a potential alternative diagnostic test especially in times like these when testing demands have surged.

The changing goalposts of vaccine effectiveness – Dr. Ameet Revankar

April 26, 2021 | News

The measured efficacy/ effectiveness of the vaccine is only a guide for approval and not a benchmark for claiming superiority of one vaccine over another.

© 2021 - All rights reserved - Dental Tribune International